Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency.

V GascoJ GiannelliL CampioniE ArvatE GhigoS GrottoliM MaccarioRoberta Giordano

Published in: Journal of endocrinological investigation (2022)

DR-HC treatment provides some benefits in patients with SAI, reducing central adiposity and improving HRQoL; however, worsening of HDL cholesterol is observed during treatment with DR-HC.

Keyphrases

insulin resistance
metabolic syndrome
adipose tissue
skeletal muscle
body mass index
physical activity
low density lipoprotein